Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®

Ítems similars

• Trends of reporting of ‘serious’vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database
  per: Moulis, Guillaume, et al.
  Publicat: (2012)
• Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
  per: Montastruc, Jean-Louis, et al.
  Publicat: (2011)
• Estimation of time devoted to adverse drug reactions assessment in an internal medicine department
  per: Tavassoli, Neda, et al.
  Publicat: (2005)
• Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
  per: Grandvuillemin, Aurélie, et al.
  Publicat: (2020)
• Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses
  per: Tavassoli, Neda, et al.
  Publicat: (2008)